Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Hypoxia-Inducible Factor: A Potential Therapeutic Target for Rheumatoid Arthritis

Author(s): Xuli Zhao, Ye Yue, Wengxiang Cheng, Jingchao Li, Yiping Hu, Ling qin and Peng Zhang

Volume 14, Issue 6, 2013

Page: [700 - 707] Pages: 8

DOI: 10.2174/1389450111314060010

Price: $65

Abstract

The hypoxic microenvironment is a clinicopathological characteristic of many diseases, such as rheumatoid arthritis (RA). As a transcription factor activating the gene expression involved in processes such as cell metabolism and angiogenesis, hypoxia-inducible factor (HIF) has a central function in adaption to altered oxygen tension and even contributes to the progression of related diseases. In RA, HIF induces angiogenesis, cell migration, and cartilage destruction, inhibits the apoptosis of synovial cells and inflammatory cells and initiates glycolysis for energy supply by upregulating specific protein levels. HIF expression in RA can be regulated in both oxygen-dependent and independent fashions, leading to the aggravation of this disease. Therefore, HIF is one of the vital RA mediators. Based on the application of HIFtargeted drug research and development in tumors, HIF is a potential therapeutic target for treating RA.

Keywords: Angiogenesis, hypoxia-inducible factor, rheumatoid arthritis, regulation, tumor therapy, therapeutic target.


Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy